Frank McCormick

About Frank McCormick

Frank McCormick is a chairman of oncology at BridgeBio Pharma.

Form D filings name Frank McCormick as a director at TheRas.

Frank McCormick reports to the SEC as a director or officer of 5 public companies, including BridgeBio Oncology Therapeutics (BBOT), Olema Pharmaceuticals (OLMA) and Chinook Therapeutics (KDNY).

Frank McCormick first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Frank McCormick in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Frank McCormick works with at each company, as listed on that company's latest Form D.

Sources

1. SECTheRas, Inc. Form D, filed May 15, 2024
2. SECForms 3, 4 and 5 filed by Frank McCormick (SEC filer 1257809)